Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Simulations Plus Inc SLP

Healthcare Medical Devices
Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. Its segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus... see more

Recent & Breaking News (NDAQ:SLP)

Simulations Plus to Participate in the Morgan Stanley 3rd Annual Life Sciences AI Summit

Business Wire 17 hours ago

Simulations Plus Announces Third Quarter Fiscal Year 2024 Earnings and Conference Call Date

Business Wire 2 days ago

QHP Capital-Backed Pro-ficiency Acquired by Simulations Plus

Business Wire 8 days ago

Simulations Plus Acquires Pro-ficiency, Creating One-of-a-Kind Platform Spanning the Drug Development Continuum

Business Wire 8 days ago

Simulations Plus to Participate in 21st Annual Craig-Hallum Institutional Investor Conference

Business Wire May 22, 2024

Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software

Business Wire May 15, 2024

U.S. FDA Renews DILIsym® Software Licenses for 7th Year

Business Wire April 4, 2024

Simulations Plus Reports Second Quarter Fiscal 2024 Financial Results

Business Wire April 3, 2024

Simulations Plus Announces Second Quarter Fiscal Year 2024 Earnings and Conference Call Date

Business Wire March 20, 2024

Simulations Plus to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor Forum

Business Wire March 13, 2024

Simulations Plus and the University of Bath Awarded New FDA Grant

Business Wire March 5, 2024

Simulations Plus Extends Collaboration with Major Toxicology Research Agency

Business Wire February 15, 2024

Simulations Plus Launches Corporate Development Initiative

Business Wire February 13, 2024

Simulations Plus to Participate in Upcoming Healthcare Conferences

Business Wire February 6, 2024

Simulations Plus Releases GastroPlus® Version 9.9

Business Wire January 30, 2024

Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant

Business Wire January 9, 2024

Simulations Plus Reports First Quarter Fiscal 2024 Financial Results

Business Wire January 3, 2024

Simulations Plus Announces Leadership Appointments Supporting Commitment to Clients and Driving Growth

Business Wire January 3, 2024

Simulations Plus Announces First Quarter Fiscal Year 2024 Earnings and Conference Call Date

Business Wire December 20, 2023

Simulations Plus Outlines Paths to Win at 2023 Investor Day

Business Wire November 14, 2023